alisertib
alisertib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Phase 2 |
Clinical Trials (1)
A Phase 2 Study of Alisertib in Combination With Paclitaxel in Patients With Small Cell Lung Cancer
Frequently asked questions
Who is developing alisertib?
alisertib is being developed by PUMA BIOTECHNOLOGY, INC..
How many clinical trials involve alisertib?
BioSniper tracks 1 clinical trial involving alisertib.
Get deeper analysis on alisertib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis